Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma. [electronic resource]
Producer: 20200103Description: 1385-1386 p. digitalISSN:- 1097-0142
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.